GHIT Fund is a public-private partnership involving the Japanese government, pharmaceutical companies, and international organizations, supporting R&D for infectious diseases in low-income regions.

Why is Ebola response support urgent now?

An Ebola outbreak caused by Bundibugyo virus in DRC has led WHO to declare a PHEIC, making rapid diagnostics critical for containment.

What technologies are supported?

The program supports rapid diagnostic and point-of-care tests that work in low-resource settings without reliable power or lab infrastructure.

Japanese companies, universities, and research institutions with innovative diagnostic technologies, especially in collaboration with global partners.

Is funding guaranteed?

Funding is not guaranteed; grants are awarded after rigorous review and selection of submitted proposals.

AI News NQ Analysis

GHIT Fund Launches Emergency Product Development Support for Ebola Virus Disease Outbreak

Key facts

GHIT Fund Launches Emergency Product Development Support for Ebola Virus Disease Outbreak
The GHIT Fund has launched emergency support for product development in response to the Ebola virus disease outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo, aiming to accelerate rapid diagnostic and point-of-care (POC) test development through Japanese innovation and international collaboration.
Source: PR TIMES
Date: Wed Jun 17 2026 23:30:01 GMT+0900 (Japan Standard Time)

Direct answer

The GHIT Fund has launched emergency support for product development in response to the Ebola virus disease outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo, aiming to accelerate rapid diagnostic and point-of-care (POC) test development through Japanese innovation and international collaboration.

Citation: GHIT Fund Launches Emergency Product Development Support for Ebola Virus Disease Outbreak (Wed Jun 17 2026 23:30:01 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Wed Jun 17 2026 23:30:01 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

The GHIT Fund has launched emergency support for product development in response to the Ebola virus disease outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo, aiming to accelerate rapid diagnostic and point-of-care (POC) test development through Japanese innovation and international collaboration.

AI Analysis

Frequently Asked Questions

Q: What is GHIT Fund?: A: GHIT Fund is a public-private partnership involving the Japanese government, pharmaceutical companies, and international organizations, supporting R&D for infectious diseases in low-income regions.
Q: Why is Ebola response support urgent now?: A: An Ebola outbreak caused by Bundibugyo virus in DRC has led WHO to declare a PHEIC, making rapid diagnostics critical for containment.
Q: What technologies are supported?: A: The program supports rapid diagnostic and point-of-care tests that work in low-resource settings without reliable power or lab infrastructure.
Q: Who can apply?: A: Japanese companies, universities, and research institutions with innovative diagnostic technologies, especially in collaboration with global partners.
Q: Is funding guaranteed?: A: Funding is not guaranteed; grants are awarded after rigorous review and selection of submitted proposals.